An interdisciplinary team led by Associate Professor at the UA College of Medicine – Phoenix and BIO5 member Dr. Melissa Herbst-Kralovetz, completed a first-of-its-kind study that could aid in the treatment, diagnosis and prevention of cervical cancer by identifying cervicovaginal metabolic signatures, or “fingerprints,” that distinguish patients with HPV, pre-cancerous cervical conditions and cancer.
Related
